News
The jury awarded him nearly $9 million in damages, and court documents found that “Johnson & Johnson had known for years that ...
A judge dismissed an attempt to use a bankruptcy court to resolve tens of thousands of claims that the company’s talcum power ...
Bankruptcy judge rejects the healthcare-products company’s third attempt to resolve mass talc lawsuits through chapter 11.
J&Js failure to win approval of an $8 billion bankruptcy plan for its talc liabilities is the latest court ruling to pare ...
BofA lowered the firm’s price target on Johnson & Johnson to $159 from $171 and keeps a Neutral rating on the shares. For Q1, the firm’s total revenue estimate is unchanged but EPS is 2% lower ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results